Comprehensive Hair Restoration using Surgical and Non-surgical Technologies

Dexoria Wiles from the Mayo Clinic presented on hair restoration technologies, focusing on exosomes and their potential in regenerative medicine. She highlighted the variability in exosome sources, particularly comparing mesenchymal stem cell-derived exosomes with platelet-derived exosomes. The key differences lie in their manufacturing; platelet exosomes are processed immediately, preserving their innate characteristics, while stem cell exosomes undergo a lengthy lab process that can alter their efficacy. Wiles emphasized the importance of understanding exosome structure, including key CD markers like CD9 and CD63, which help differentiate true exosomes from other cell debris. A study she referenced examined the effects of a topical human platelet extract on hair thinning, showing promising results in scalp coverage and hair density over nine months of application. The research indicated that exosomes could provide a non-invasive alternative to current treatments like PRP injections, offering potential for consistent at-home application. Wiles concluded by discussing future directions for exosome research, including bioengineered exosomes loaded with hair regrowth pathways and the need for ongoing FDA studies to ensure safety and efficacy in clinical applications.